Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease

被引:8
作者
Hirayama, Masahiro [1 ]
Azuma, Eiichi [2 ]
Nakagawa-Nakazawa, Atsuko [3 ]
Kumamoto, Tadashi [1 ]
Iwamoto, Shotaro [1 ]
Amano, Keishiro [1 ]
Tamaki, Shigehisa [4 ]
Usui, Eiji [4 ]
Komada, Yoshihiro [1 ]
机构
[1] Mie Univ, Dept Pediat, Grad Sch Med, Tsu, Mie 514, Japan
[2] Mie Univ, Dept Cell Transplantat, Grad Sch Med, Tsu, Mie 514, Japan
[3] Natl Ctr Child Hlth & Dev, Dept Pathol, Setagaya Ku, Tokyo, Japan
[4] Ise Red Cross Hosp, Dept Internal Med, Ise, Mie, Japan
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2013年 / 98卷 / 01期
关键词
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; PERIPHERAL-BLOOD; CLINICAL-TRIALS; EXTRACORPOREAL PHOTOCHEMOTHERAPY; CHRONIC GVHD; BONE-MARROW; B-CELLS;
D O I
10.3324/haematol.2012.069815
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although there are National Institutes of Health consensus criteria for the global assessment of chronic graft-versus- host disease, no validated biomarkers have been established for this disease. Furthermore, whereas the role of T cells, B cells, and dendritic cells in chronic graft-versus-host disease has been established, the contribution of monocytes has not been clearly addressed. Using an enzyme-linked immunospot assay, we measured the spot-forming cells for interferon-gamma, interleukin-4, interleukin-10, and interleukin-17 in unstimulated peripheral blood of patients following allogeneic hematopoietic stem cell transplantation. Other immunological examinations, including skin biopsy, were also done. Fifty-seven patients were enrolled. Interleukin-10 spot-forming cells were evaluable for therapeutic monitoring in 16 patients with chronic graft-versus-host disease. The number of interleukin-10 spot-forming cells in patients with active chronic graft-versus-host disease was significantly higher than the number in those with no or inactive chronic graft-versus-host disease. Interleukin-10 was predominantly produced by monocytes. CD29 expression on monocytes in patients with active chronic graft-versus-host disease was elevated. The level of plasma fibronectin, a ligand of CD29, correlated with the number of interleukin-10 spot-forming cells. Immunohistochemical analysis of the skin in active chronic graft-versus-host disease showed that infiltrating CD29(+) monocytes might produce interleukin-10. A novel biomarker, interleukin-10 spot-forming cells, shows promise as both a diagnostic and prognostic indicator for chronic graft-versus-host disease, and may allow for early intervention prior to the onset of the disease. Measurement of interleukin-10 spot-forming cells would be helpful in clinical trials and in patients' management. (UMIN-CTR UMIN000006733; www.umin.ac.jp/ctr/index/htm) (C) 2013 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2012.069815
引用
收藏
页码:41 / 49
页数:9
相关论文
共 48 条
[1]   Increased donor CD86+CD14+cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease [J].
Arpinati, Mario ;
Chirumbolo, Gabriella ;
Marzocchi, Giulia ;
Baccarani, Michele ;
Rondell, Damiano .
TRANSPLANTATION, 2008, 85 (12) :1826-1832
[2]   TGF-β in allogeneic stem cell transplantation:: friend or foe? [J].
Banovic, T ;
MacDonald, KPA ;
Morris, ES ;
Rowe, V ;
Kuns, R ;
Don, A ;
Kelly, J ;
Ledbetter, S ;
Clouston, AD ;
Hill, GR .
BLOOD, 2005, 106 (06) :2206-2214
[3]  
BERGIJK EC, 1992, AM J PATHOL, V140, P1147
[4]   Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells [J].
Clark, FJ ;
Gregg, R ;
Piper, K ;
Dunnion, D ;
Freeman, L ;
Griffiths, M ;
Begum, G ;
Mahendra, P ;
Craddock, C ;
Moss, P ;
Chakraverty, R .
BLOOD, 2004, 103 (06) :2410-2416
[5]   Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD [J].
Couriel, DR ;
Hosing, C ;
Saliba, R ;
Shpall, EJ ;
Anderlini, P ;
Rhodes, B ;
Smith, V ;
Khouri, I ;
Giralt, S ;
de Lima, M ;
Hsu, Y ;
Ghosh, S ;
Neumann, J ;
Andersson, B ;
Qazilbash, M ;
Hymes, S ;
Kim, S ;
Champlin, R ;
Donato, M .
BLOOD, 2006, 107 (08) :3074-3080
[6]   Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes [J].
Cox, K ;
North, M ;
Burke, M ;
Singhal, H ;
Renton, S ;
Aqel, N ;
Islam, S ;
Knight, SC .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (05) :1142-1152
[7]   Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease [J].
Craciun, LI ;
Stordeur, P ;
Schandené, L ;
Duvillier, H ;
Bron, D ;
Lambermont, M ;
Goldman, M ;
Dupont, E .
TRANSPLANTATION, 2002, 74 (07) :995-1000
[8]   Rituximab for steroid-refractory chronic graft-versus-host disease [J].
Cutler, Corey ;
Miklos, David ;
Kim, Haesook T. ;
Treister, Nathaniel ;
Woo, Sook-Bin ;
Bienfang, Don ;
Klickstein, Lloyd B. ;
Levin, Jesse ;
Miller, Katherine ;
Reynolds, Carol ;
Macdonell, Rebecca ;
Pasek, Mildred ;
Lee, Stephanie J. ;
Ho, Vincent ;
Soiffer, Robert ;
Antin, Joseph H. ;
Ritz, Jerome ;
Alyea, Edwin .
BLOOD, 2006, 108 (02) :756-762
[9]   National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report [J].
Filipovich, AH ;
Weisdorf, D ;
Pavletic, S ;
Socie, G ;
Wingard, JR ;
Lee, SJ ;
Martin, P ;
Chien, J ;
Przepiorka, D ;
Couriel, D ;
Cowen, EW ;
Dinndorf, P ;
Farrell, A ;
Hartzman, R ;
Henslee-Downey, J ;
Jacobsohn, D ;
McDonald, G ;
Mittleman, B ;
Rizzo, JD ;
Robinson, M ;
Schubert, M ;
Schultz, K ;
Shulman, H ;
Turner, M ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (12) :945-956
[10]   Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group [J].
Fujii, Hisaki ;
Cuvelier, Geoff ;
She, Kevin ;
Aslanian, Soudabeh ;
Shimizu, Hiromi ;
Kariminia, Amina ;
Krailo, Mark ;
Chen, Zhengjia ;
McMaster, Rob ;
Bergman, Axel ;
Goldman, Frederick ;
Grupp, Stephen A. ;
Wall, Donna A. ;
Gilman, Andrew L. ;
Schultz, Kirk R. .
BLOOD, 2008, 111 (06) :3276-3285